Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
|ClinicalTrials.gov Identifier: NCT01119573|
Recruitment Status : Unknown
Verified May 2010 by National Cancer Institute (NCI).
Recruitment status was: Not yet recruiting
First Posted : May 7, 2010
Last Update Posted : June 22, 2010
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This research study is studying at biomarkers in tissue samples from patients with stage I or stage III endometrial cancer.
|Condition or disease||Intervention/treatment|
|Endometrial Cancer||Genetic: RNA analysis Genetic: microarray analysis Genetic: reverse transcriptase-polymerase chain reaction Other: laboratory biomarker analysis|
- To identify microRNA expression patterns associated with lymph node metastasis in samples from patients with endometrial cancer.
OUTLINE: Banked tumor tissue specimens are analyzed for microRNA expression profiling by microarray analysis and reverse transcriptase-PCR assays.
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Micro RNA's Associated With Lymph Node Metastasis in Endometrial Cancer|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||June 2010|
- Association between microRNA expression and lymph node metastasis
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01119573
|Principal Investigator:||David S. Miller, MD||Simmons Cancer Center|